Why Idenix Pharmaceuticals (IDIX) Exploded to a One-Year High Today (Update)

Update (4:07 p.m.): Updated with Monday market close information.

NEW YORK (TheStreet) -- Idenix Pharmaceuticals  (IDIX) shares exploded to a new 52-week high of $24.21 on Monday amid news that Merck  (MRK) would purchase the biotechnology company for $3.85 billion as it tries to strengthen its position in the increasingly competitive hepatitis C sector.

Merck will pay $24.50 a share in cash for Idenix, more than triple the company's closing price of $7.23 on Friday.

"Idenix has established a promising portfolio of hepatitis C candidates,'' said Dr. Roger Perlmutter, the president of Merck Research Laboratories, in a statement Monday. 

Must Read: Merck Buys Idenix for $3.9B in Yet Another Blockbuster Hep C Deal

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Idenix closed up 229.05%, or $16.56, to $23.79. More than 40.8 million shares changed hands, which eclipsed the average volume of 1.235 million.

For more on this story, read TheStreet's Adam Feuerstein's article here.

IDIX Chart

IDIX data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%